Stock Report

All about this stock under one free report Last Updated: 09-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Novanta Inc. (NOVT)

Stock Card factsheet share-fund-plan-icon

$138.31

up-down-arrow $2.03 (1.49%)

As on 08-May-2026 16:00EDT

Market cap

info icon

$4,946 Mln

Revenue (TTM)

info icon

$981 Mln

P/E Ratio

info icon

94.5

P/B Ratio

info icon

3.4

Div. Yield

info icon

0 %

Value Research Rating

--

Quality Score fund-quick-summary-circle

Quality Score/10

Growth Score fund-quick-summary-circle

Growth Score/10

Valuation Score fund-quick-summary-circle

Valuation Score/10

Momentum Score fund-quick-summary-circle

Momentum Score/10

Know more link icon Explore 5 star rated stocks link icon

Novanta (NOVT) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio
NASDAQ
NASDAQ

Stock Range

Today’s Range

Low: 134.92 High: 139.38

52 Week Range

Low: 98.27 High: 149.95

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    0.1 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    24.7

  • Debt to EquityDebt to Equity information

    0.3

  • Book ValueBook Value information

    $34

  • EPSEPS information

    $1.4

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    35,610,633

10 Years Aggregate

CFO

$774.92 Mln

EBITDA

$1,113.69 Mln

Net Profit

$425.08 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Novanta (NOVT)
16.2 20.0 3.7 16.3 -5.2 1.4 25.6
BSE Sensex
-8.7 3.6 -7.5 -4.2 8.2 9.5 11.9
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 08-May-2026  |  #As on 26-Oct-2023
Company
2025
2023
2022
2021
2020
2019
Novanta (NOVT)
-22.1 23.9 -22.9 49.2 33.7 40.4
S&P Small-Cap 600
4.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Novanta (NOVT)
138.3 4,946.3 980.6 53.8 10.7 5.2 94.5 3.4
Ballard Power Systems (BLDP)
4.1 1,441.1 101.1 -92.5 -84.5 -14.7 -- 2.3
Celestica
375.6 43,178.2 13,810.1 959.7 8.6 47.1 45.6 22.9

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Novanta (NOVT)

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates...  Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts. Address: 125 Middlesex Turnpike, Bedford, MA, United States, 01730  Read more

  • CEO & Chairman of the Board

    Mr. Matthijs Glastra

  • CEO & Chairman of the Board

    Mr. Matthijs Glastra

  • Headquarters

    Bedford, MA

  • Website

    https://www.novanta.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Novanta (NOVT)

The share price of Novanta Inc (NOVT) is $138.31 (NASDAQ) as of 08-May-2026 16:00 EDT. Novanta Inc (NOVT) has given a return of -5.21% in the last 3 years.

The P/E ratio of Novanta Inc (NOVT) is 94.49 times as on 07-May-2026.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
85.51
3.50
2024
86.17
7.41
2023
83.37
9.02
2022
66.05
8.47
2021
125.46
12.11

The 52-week high and low of Novanta Inc (NOVT) are Rs 149.95 and Rs 98.27 as of 09-May-2026.

Novanta Inc (NOVT) has a market capitalisation of $ 4,946 Mln as on 07-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Novanta Inc (NOVT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.